Haleon (HLNCF) Return on Assets (2023 - 2025)

Haleon (HLNCF) recorded quarterly Return on Assets of 0.0% in Q4 2025, down 46.72% on a QoQ basis from 0.0% in Q4 2024, and little changed year-over-year from 0.0% in Q4 2024.

Haleon (HLNCF) Return on Assets (2023 - 2025) Analysis & Trends

Haleon has disclosed Return on Assets across 3 years of filings, most recently posting 0.0% for Q4 2025.

  • Quarterly Return on Assets changed 0.0% year-over-year to 0.0% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
  • Return on Assets slipped to 0.0% in Q4 2025, from 0.0% in the prior quarter.
  • Over five years, Return on Assets peaked at 0.0% in Q4 2023 and troughed at 0.0% in Q4 2025.
  • A 3-year average of 0.0% and a median of 0.0% in 2024 frame the typical range for Return on Assets.
  • Biggest YoY gain for Return on Assets was 0 bps in 2024; the steepest drop was 0 bps in 2024.
  • Tracing HLNCF's Return on Assets over 3 years: stood at 0.0% in 2023, then slumped by 53 bps to 0.0% in 2024, then plunged by 47 bps to 0.0% in 2025.
  • Business Quant data shows HLNCF's Return on Assets at 0.0% in Q4 2025, 0.0% in Q4 2024, and 0.0% in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 0.00%
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 0.00%
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 0.00%
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 0.00%
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 0.00%
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 0.00%
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 0.00%
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 0.00%
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 0.00%
10 Haleon - - - 0.00%

Historic Data

Download Data
DateValue
Dec 31, 2025 0.00%
Dec 31, 2024 0.00%
Jun 30, 2024 0.00%
Dec 31, 2023 0.00%